Overview: HSV2 Qualitative PCR TestIntroduction: The HSV2 Qualitative PCR Test detects herpes simplex virus type 2 (HSV-2) DNA to confirm active genital herpes infection, causing sores or pain. Aligned with 2023 IDSA guidelines, it uses PCR for high sensitivity, aiding in infectious disease screening. This test is critical for guiding diagnosis, antiviral therapy, and improving outcomes in virology for patients with suspected acute HSV-2 infection, ensuring timely treatment to reduce severity and transmission.
Other Names: HSV 2 PCR Assay, Genital Herpes DNA Test.
FDA Status: Laboratory-developed test (LDT), meeting virology standards for diagnostic accuracy.
Historical Milestone: HSV PCR testing began in the 1990s with advances in molecular diagnostics. Qualitative PCR assays improved in the 2000s, enhancing active infection detection.
Purpose: Confirms active HSV-2 infection, guides antiviral therapy, and detects HSV-2 DNA in patients with genital sores or pain.
Test Parameters: 1. HSV Type 2 DNA
Pretest Condition: No fasting required. Collect swab, CSF, blood, serum, plasma, or saliva at any time. Report symptoms like genital sores, pain, or fever, and list medications.
Specimen: 1-2 swabs (sterile swab/transport medium), 1-2 mL CSF (sterile container), 2-5 mL whole blood (EDTA), 2-5 mL serum (SST), 2-4 mL plasma (EDTA), or 1-2 mL saliva (sterile container). Centrifuge blood, serum, or plasma within 1 hour. Transport in a biohazard bag within 24 hours.
Sample Stability at Room Temperature: 24 hours
Sample Stability at Refrigeration: 48 hours
Sample Stability at Frozen: Not frozen
Medical History: Document genital sores, pain, fever, or history of HSV-2 exposure. Include current medications, especially antivirals, and recent infections.
Consent: Written consent required, detailing the tests purpose, diagnostic implications, and potential need for antiviral therapy or counseling.
Procedural Considerations: Uses PCR to detect HSV-2 DNA. Results are available in 3-5 days, enabling rapid clinical decisions. Performed in laboratories, often for acute genital herpes diagnosis.
Factors Affecting Result Accuracy: Improper sample handling, contamination, or low viral load can affect results. Antiviral therapy may suppress DNA detection.
Clinical Significance: Positive HSV-2 DNA confirms active infection, prompting antiviral therapy (e.g., acyclovir). Negative results may require repeat testing in early infection.
Specialist Consultation: Consult an infectious disease specialist or gynecologist for result interpretation and treatment planning.
Additional Supporting Tests: HSV-2 IgM, HSV-2 IgG, or viral culture to confirm acute or past HSV-2 infection.
Test Limitations: False negatives may occur in early infection or low viral load. Clinical correlation and repeat testing are needed.
References: IDSA Herpes Guidelines, 2023; Clinical Infectious Diseases, Corey L, 2022.
